Search

Xiaojing S Wang

from Tampa, FL
Age ~60
Get Report
Also known as:
Xi Li Wang, Xi L Wang, Xi S Wang, Xi I Wang, Xili Wang, Xi S Li
Related to:
Hou Q Ma, 83Ralph Walker, 55Irving Y Wang, 65Jeremy C Austin, 44Deneen S WangDavid MenteshashviliAlex B Wang, 32Archac W MiguelChao WangSharon Wang, 63Michael H Ma, 43Jianan Lu, 68
Connected to:
Adele R Wang, 107Aiyuan Wang, 52Akiet Wang, 74Alene P Wang, 52Amanda K Wang, 46Amei Wang, 61Amity H Wang, 70Amy Wang, 59Anastasia S Wang, 85Ange Wang, 35

Xiaojing Wang Phones & Addresses

  • Tampa, FL
  • Santa Clara, CA
  • Land O Lakes, FL
  • Richardson, TX
  • Plano, TX
  • Edison, NJ
  • Pace, FL
  • Hillsboro Bch, FL

Professional Records

Lawyers & Attorneys

Xiaojing Wang Photo 1

Xiaojing Wang - Lawyer

View page
ISLN:
1000851998
Admitted:
2018

Publications

Us Patents

[4,5]-Fused-3,6-Disubstituted-Pyridazines With Sulfur-Containing Substituents In Position Three For The Treatment Of Neoplasia

View page
US Patent:
6486158, Nov 26, 2002
Filed:
Jun 6, 2001
Appl. No.:
09/875107
Inventors:
Xiaojing Wang - Livermore CA
Gerhard Sperl - Horsham PA
Paul Gross - Stockton CA
Rifat Pamukcu - Spring House PA
Gary A. Piazza - Doylestown PA
Assignee:
Cell Pathways, Inc. - Horsham PA
International Classification:
C07D47104
US Classification:
514248, 544105, 544184, 544180, 544235, 544236, 544237
Abstract:
[4,5]-Fused-3,6 disubstituted-pydidazines of Formula I are useful for inducing or promoting apoptosis and for arresting uncontrolled neoplastic cell proliferation, and are specifically useful in the arresting and treatment of neoplasia: wherein Y and Y are independently selected from the group consisting of (CH ) ,âC(X)âNHâ,â(CH ) âC(X)âOâ, and X is O or S; R is selected from the group consisting of lower alkyl, lower alkenyl, lower alkynyl, and substituted or unsubstituted phenyl, pyridinyl, and the like; R is selected from the group consisting of substituted or unsubstituted phenyl, benzyl, pyridinyl, and the like; âAâ is a benzene ring fused with the pyridazine ring; and R is independently selected in each instance form the group consisting of halogen, lower alkyl, and the like.

Antibacterial 4,5-Substituted Aminoglycoside Analogs Having Multiple Substituents

View page
US Patent:
8114856, Feb 14, 2012
Filed:
Jan 10, 2011
Appl. No.:
12/987842
Inventors:
Eric E. Swayze - Encintas CA, US
Stephen Hanessian - Beaconsfield, CA
Janek Szychowski - Val Belair, CA
Susanta Sekhar Adhikari - Calcutta, IN
Kandasamy Pachamuthu - North York, CA
Xiaojing Wang - Foster City CA, US
Michael T. Migawa - Carlsbad CA, US
Richard H. Griffey - Vista CA, US
Assignee:
ISIS Pharmaceuticals, Inc. - Carlsbad CA
International Classification:
A01N 43/04
A61K 31/715
US Classification:
514 54, 514 23, 536 172, 536 187, 5361231
Abstract:
The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.

4-Substituted Pyridin-3-Yl-Carboxamide Compounds And Methods Of Use

View page
US Patent:
8435976, May 7, 2013
Filed:
Sep 8, 2010
Appl. No.:
12/877202
Inventors:
Xiaojing Wang - Foster City CA, US
Assignee:
F. Hoffmann-La Roche - Basel
International Classification:
A01N 43/00
A01N 43/40
A61K 31/33
A61K 31/497
A61K 31/445
A61K 31/44
C07D 403/00
C07D 405/00
C07D 409/00
C07D 417/00
US Classification:
514183, 5142531, 514318, 514342, 544364, 5462707
Abstract:
The invention relates to compounds of formula (I) which are useful as kinase inhibitors, more specifically useful as PIM kinase inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same, either alone or in combination, to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

Pyrazol-4-Yl-Heterocyclyl-Carboxamide Compounds And Methods Of Use

View page
US Patent:
8436001, May 7, 2013
Filed:
Apr 6, 2011
Appl. No.:
13/080762
Inventors:
Xiaojing Wang - Foster City CA, US
Assignee:
F. Hoffmann-La Roche AG - Basel
International Classification:
A61K 31/497
A61K 31/506
US Classification:
51425505, 514336, 544333, 544405, 5462754, 5483641
Abstract:
Pyrazol-4-yl-heterocyclyl-carboxamide compounds of Formula I, including stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof, wherein X is a thiazolyl, picolinyl, pyridinyl, or pyrimidinyl, are useful for inhibiting Pim kinase, and for treating disorders such as cancer mediated by Pim kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Pyrazol-4-Yl-Heterocyclyl-Carboxamide Compounds And Methods Of Use

View page
US Patent:
8614206, Dec 24, 2013
Filed:
Sep 26, 2012
Appl. No.:
13/627262
Inventors:
Mizio Matteucci - Saffron Walden, GB
Andrew Sharpe - Saffron Walden, GB
Minghua Sun - Burlingame CA, US
Xiaojing Wang - Foster City CA, US
Vickie H. Tsui - Burlingame CA, US
Assignee:
F. Hoffmann-La Roche AG - Basel
International Classification:
A61K 31/4965
A61K 31/44
A61K 31/415
A01N 43/40
A01N 43/56
C07D 401/00
C07D 403/00
C07D 403/02
US Classification:
5142102, 51425505, 514336, 514406, 514407, 544333, 544405, 5462754, 5483641
Abstract:
Pyrazol-4-yl-heterocyclyl-carboxamide compounds of Formula I, including stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof, wherein X is thiazolyl, pyrazinyl, pyridinyl, or pyrimidinyl, are useful for inhibiting Pim kinase, and for treating disorders such as cancer mediated by Pim kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Carboxamide Inhibitors Of Tgfbeta

View page
US Patent:
20060281763, Dec 14, 2006
Filed:
Mar 27, 2006
Appl. No.:
11/390980
Inventors:
Jonathan Axon - Milpitas CA, US
Sarvajit Chakravarty - Mountain View CA, US
Barry Hart - Palo Alto CA, US
Glenn McEnroe - San Mateo CA, US
Alison Murphy - Milpitas CA, US
Karen Pontius - Aromas CA, US
Peijue Sheng - San Jose CA, US
Xiaojing Wang - Foster City CA, US
Shanthi Yellapregada - Milpitas CA, US
International Classification:
C07D 403/14
C07D 403/02
A61K 31/506
US Classification:
514256000, 544328000
Abstract:
Certain appropriately substituted forms of pyrimidine having a pyridylamine group at C-4 of the pyrimidine and an amide group on the pyridine ring are useful in the treatment of conditions associated with excessive TGFβ activity.

Novel Compounds For Treating Proliferative Diseases

View page
US Patent:
20100121052, May 13, 2010
Filed:
Jun 9, 2009
Appl. No.:
12/456032
Inventors:
Rama Jain - Fremont CA, US
Xiaodong Lin - Walnut Creek CA, US
Simon C. Ng - Walnut Creek CA, US
Keith B. Pfister - San Ramon CA, US
Savithri Ramurthy - Walnut Creek CA, US
Alice Rico - Castro Valley CA, US
Sharadha Subramanian - San Ramon CA, US
Xiaojing Michael Wang - Livermore CA, US
International Classification:
C07D 239/84
C07D 417/10
C07D 401/12
C07D 413/12
C07D 401/14
C07D 413/14
US Classification:
544119, 544292, 544284
Abstract:
The invention provides novel compounds that are inhibitors of PDK1. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.

Imidazoquinoline Compounds

View page
US Patent:
20110217323, Sep 8, 2011
Filed:
May 16, 2011
Appl. No.:
13/108937
Inventors:
Nicholas VALIANTE - Fremont CA, US
Feng Xu - Walnut Creek CA, US
Xiaodong Lin - Orinda CA, US
Daniel Chu - Santa Clara CA, US
Xiaojing Michael Wang - Livermore CA, US
Assignee:
NOVARTIS VACCINES & DIAGNOSTICS, INC. - Emeryville CA
International Classification:
A61K 39/00
C07D 471/04
A61P 37/02
A61P 37/04
A61P 35/00
US Classification:
4241841, 546 82
Abstract:
The invention provides novel compositions comprising imidazoquinoline compounds. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an) other agent(s).
Control profile
Xiaojing S Wang from Tampa, FL, age ~60 Get Report